Abstract
The polyamines putrescine (1,4-diaminobutane), spermidine (1,8-diamino-4-azaoctane, 2), and spermine (1,12-diamino-4,9-diazadodecane, 3) (Fig. 1) are ubiquitous polycationic compounds that are found in significant amounts in nearly every prokaryotic and eukaryotic cell type. Spermidine and spermine primarily exist in aqueous solution at pH 7.4 as fully protonated polycations and possess the pKa values indicated in Fig. 1 (1). This high degree of positive charge is an important factor in the biological functions of these molecules, and, as will be discussed later in this chapter, alterations in the pKa of polyamine nitrogens can affect and disrupt their cellular function. Polyamines are widely distributed in nature and are known to be required in micromolar to millimolar concentrations to support a wide variety of cellular functions. However, data that establish the precise role of the polyamines and their analogs in cellular processes are incomplete. The ongoing identification of new functions for the polyamines ensures that new avenues for research are arising continuously in an extremely diverse set of disciplines. The human and mammalian pathways for polyamine metabolism have been extensively studied, and analogous pathways have been elucidated for a relatively small number of organisms. There are important interspecies differences in polyamine metabolism, especially among eukaryotic cells, plants, and some bacteria and protozoa. In some prokaryotes, only putrescine and spermidine are synthesized, whereas in other cases, such as certain thermophilic bacteria, polyamines with chains longer than spermine are found. In some parasitic organisms, there are additional enzymes that are not present in the host cell, and, as such, provide a target for the design of specific antiparasitic agents. The enzymes involved in human and mammalian polyamine metabolism are reasonably similar, and inhibitors targeted to these enzymes rely on the observation that polyamine metabolism is accelerated, and polyamines are required in higher quantities, in target cell types. The diversity of biological research in the polyamine field is the subject of an excellent book (2). Keeping in mind the diverse nature of polyamine distribution and function, it is reasonable to assume that carefully designed polyamine analogs could have the potential to disrupt polyamine metabolism, and thus such agents have been investigated as potential therapeutic agents in vitro and in vivo. The polyamine pathway represents an important target for chemotherapeutic intervention because depletion of polyamines results in the disruption of a variety of cellular functions and may, in specific cases, result in cytotoxicity (3,4). This chapter will summarize the development of synthetic derivatives of the polyamines, and describe their use as potential chemotherapeutic agents. A comprehensive review of polyamine biosynthesis inhibitors (4) and a review of the role of polyamines in normal and tumor cell metabolism (5) have recently been published.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bergeron, R. J., McManis, J. S., Weimar, W. R., et al. (1995) The role of charge in polyamine analog recognition. J. Med. Chem. 38, 2278–2285.
Cohen, S. A. (ed.) (1998) Guide to the Polyamines. Oxford University Press, New York.
Sunkara, P. S., Baylin, S. B., and Luk, G. D. (1987) Inhibitors of polyamine biosynthesis: Cellular in vivo effects on tumor proliferation. In: Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies (McCann, P. P., Pegg, A. E., and Sjoerdsma, A., eds.), Academic Press, New York, pp. 121–
Casero, Jr., R. A. and Woster, P. M. (2001) Terminally alkylated polyamine analogues as chemotherapeutic agents. J. Med. Chem. 44, 1–29.
Gerner, E. W. and Meyskens, F. L. (2004) Polyamines and cancer: Old molecules, new understanding. Nat. Rev. Cancer 4, 781–792.
Pegg, A. E. and McCann, P. P. (1992) S-adenosylmethionine decarboxylase as an enzyme target for therapy. Pharmacol. Ther. 56, 359–377.
Pegg, A. E. (1988) Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48, 759–774.
Murikami, Y., Matsufuji, S., Kameji, T., et al. (1992) Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360, 597–599.
Metcalf, B. W., Bey, P., Danzin, C., Jung, M. J., Casara, P., and Vevert, J. P. (1978) Catalytic, irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc. 100, 2551–2553.
Tang, K.-C., Mariuzza, R., and Coward, J.K. (1981) Synthesis and evaluation of some stable multisubstrate adducts as specific inhibitors of spermidine synthase. J. Med. Chem. 24, 1277–1284.
Woster, P. M., Black, A. Y., Duff, K. J., Coward, J. K., and Pegg, A. E. (1989) Synthesis and biological evaluation of S-adenosyl-1,12-diamino-3-thio-9-azadodecane, a multisubstrate adduct inhibitor of spermine synthase. J. Med. Chem. 32, 1300–1307.
Recsei, P. A. and Snell, E. E. (1984) Pyruvoyl enzymes. Ann. Rev. Biochem. 53, 357–387.
Danzin, C., Marchal, P., and Casara, P. (1990) Irreversible inhibition of rat S-adenosylmethioninedecarboxylase by 5′[(Z)-4-amino-2-butenyl]methylamino-5′-deoxyadenosine. Biochem. Pharmacol. 40, 1499–1503.
Marchant, P., Dredar, S., Manneh, V., et al. (1989) A selective inhibitor of N8-acetylspermidine deacetylation in mice and HeLa cells without effects on histone deacetylation. Arch. Biochem. Biophys. 15, 128–136.
Casero, R. A. and Pegg, A. E. (1993) Spermidine/spermine-N1-acetyltransferase-the turning point in polyamine metabolism. FASEB J. 7, 653–661.
Cullis, P. M., Green, R. E., Merson-Davies, L., and Travis, N. G. (1998) Chemical highlights of polyamine transport. Biochem. Soc. Trans. 26, 595–601.
Seiler, N., Delcros, J. G., and Moulinoux, J. P. (1996) Polyamine transport in mammalian cells. An update. Int. J. Biochem. Cell Biol. 8, 843–861.
Kashiwagi, K., Endo, H., Kobayashi, H., Takio, K., and Igarashi, K. (1995) Spermidinepreferential uptake system in Escherichia coli. ATP hydrolysis by PotA protein and its association with membrane. J. Biol. Chem. 270, 25377–25382.
Seiler, N. (2003) Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr. Drug Targets 7, 565–585.
Edwards, M. L., Prakash, N. J., Stemerick, D. M., et al. (1990) Polyamine analogues with antitumor activity. J. Med. Chem. 33, 1369–1375.
Edwards, M. L., Snyder, R. D., and Stemerick, D. M. (1991) Synthesis and DNA-binding properties of polyamine analogues. J. Med. Chem. 34, 2414–2420.
Porter, C. W. and Sufrin, J. (1986) Interference with polyamine biosynthesis and/or function by analogues of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res. 6, 525–542.
Bergeron, R. J., Neims, A. H., McManis, J. S., et al. (1988) Synthetic polyamine analogues as antineoplastics. J. Med. Chem. 31, 1183–1190.
Yajima, H., Takeyama, M., Kanaki, J., Nishimura, O., and Fujino, M. (1978) Studies on peptides. LXXX. NG-Mesitylene-2-sulfonylarginine. Chem. Pharm. Bull. 26, 3752–3757.
Roemmele, R. C., and Rappoport, H. (1998) Removal of N-arylsulfonyl groups from hydroxy α-amino acids. J. Org. Chem. 53, 2367–2371.
Porter, C. W., Berger, F. G., Pegg, A. E., Ganis, B., and Bergeron, R. J. (1987) Regulation of ornithine decarboxylase activity by spermidine or the spermidine analog N1, N8-bis(ethyl)spermidine (BES). Biochem. J. 242, 433–440.
Casero, R. A., Ervin, S. J., Celano, P., Baylin, S. B., and Bergeron, R. J. (1989) Differential response to treatment with bis(ethyl)polyamine analogues between human small cell lung carcinoma and undifferentiated large cell lung carcinoma in culture. Cancer Res. 49, 639–643.
Porter, C. W., Ganis, B., Libby, P. R., and Bergeron, R. J. (1991) Correlations between polyamine analogue-induced increases in spermidine/spermine-N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res. 51, 3715–3720.
Casero, R. A., Mank, A. R., Xiao, L., Smith, J., Bergeron, R. J., and Celano, P. (1992) Steady-state messenger RNA and activity correlates with sensitivity to N1, N12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res. 52, 5359–5363.
Bergeron, R. J., Hawthorne, T. R., Vinson, J. R. T., Beck, D. E., Jr., and Ingeno, M. J. (1989) Role of the methylene backbone in the antiproliferative activity of polyamine analogues in L1210 cells. Cancer Res. 49, 2959–2964.
Bergeron, R. J., McManis, J. S., Liu, C. Z, et al. (1994) Antiproliferative properties of polyamine analogues: a structure-activity study. J. Med. Chem. 37, 3464–3476.
Bergeron, R. J., Wiegand, J., McManis, J. S., et al. (2001) Polyamine analogue antidiarrheals: a structure-activity study. J. Med. Chem. 44, 232–244.
Berchtold, C. M., Tamez, P., Kensler, T. W., and Casero, R. A. (1998) Inhibition of cell growth in CaCO2 cells by the polyamine analogue N1, N12-bis(ethyl)spermine is preceded by a reduction in MYC oncoprotein levels. J. Cell Physiol. 174, 380–386.
Gabrielson, E. W., Pegg, A. E., and Casero, R. A. (1999) The induction of spermidine/spermine-N1-acetyltransferase (SSAT) is a common event in the response of human primary non-small cell lung carcinomas to exposure to a new antitumor polyamine analogue, N1, N11-bis(ethyl)norspermine. Clin. Cancer Res. 5, 1638–1641.
Wilding, G., King, D., Tutsch, K., et al. (2004) Phase I trial of the polyamine analog N1, N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumors. Invest. New Drugs. 22, 131–8.
Sninsky, C. A. and Bergeron, R. (1993) Potent anti-diarrheal activity of a new class of compounds: synthetic analogs of the polyamine pathway. Gastroenterology 104, A584.
Bergeron, R. J., Weimar, W. R., Luchetta, G., et al. (1995) Metabolism and pharmacokinetics of N1, N11-diethylnorspermine. Drug Metab. Disp. 23, 1117–1125.
Bergeron, R. J., Weimer, W. R., Luchetta, G., Sninsky, C. A., and Wiegand, J. (1996) Metabolism and pharmacokinetics of N1, N14-diethylhomospermine. Drug Metab. Disp. 24, 334–343.
Bergeron, R. J., Yao, G. W., Yao, H., et al. (1996) Metabolically programmed polyamine analogue antidiarrheals. J. Med. Chem. 39, 2461–2471.
Basu, H. S., Pellarin, M., Feuerstein, B. G., Deen, D. F., and Marton, L. J. (1991) Effect of N1, N14-bis(ethyl)homospermine (BE-4X4) on the growth of U251, MG and SF-188 brain tumor cells. Int. J. Cancer 30, 873–878.
Basu, H. S., Pellarin, M., Feuerstein, B. G., Deen, D. F., and Marton, L. J. (1993) Effects of the polyamine analogs BE-3-7-3, 3-8-3, and BE-3-8-3 on human brain tumor cell growth and survival. Anticancer Res. 13, 1525–1532.
Jeffers, L., Church, D., Basu, H., Marton, L., and Wilding, G. (1997) Effects of the polyamine analogues BE-4-4-4-4, BE-3-7-3 and BE-3-3-3 on the proliferation of three prostate cancer cell lines. Cancer Chemother. Pharmacol. 40, 172–179.
Reddy, V. K., Valasinas, A., Sarkar, A., Basu, H. S., Marton, L. J., and Frydman, B. (1998) Conformationally restricted analogues of 1N,12N-bisethylspermine: synthesis and growth inhibitory effects on human tumor cell lines. J. Med. Chem. 41, 4723–4732.
Seiler, N., Delcros, J. G., Vaultier, M., et al. (1996) Bis(7-amino-4-azaheptyl)dimethylsilane and bis(7-ethylamino-4-azaheptyl)dimethylsilane: inhibition of tumor cell growth in vitro and in vivo. Cancer Res. 56, 5624–5630.
Waters, W. R., Frydman, B., Marton, L. J., et al. (2000) [1N,12N]Bis(ethyl)-cis-6,7-dehydrospermine: a new drug for treatment and prevention of Cryptosporidium parvum infection of mice deficient in T-cell receptor alpha. Antimicrobial Agents Chemother. 44, 2891–2894.
Frydman, B., Porter, C. W., Maxuitenko, Y., et al. (2003) A novel polyamine analog (SL-11093) inhibits growth of human prostate tumor xenografts in nude mice. Cancer Chemother. Pharmacol. 51, 488–492.
Valasinas, A., Sarkar, A., Reddy, V., Marton, L. J., Basu, H. S., and Frydman, B. (2001) Conformationally restricted analogues of 1N,14N-bisethylhomospermine (BE-4-4-4): Synthesis and growth inhibitory effects on human prostate cancer cells. J. Med. Chem. 44, 390–403.
Frydman, B., Blohkin, A. V., Brummel, S., et al. (2003) Cyclopropane-containing polyamine analogues are efficient growth inhibitors of a human prostate tumor xenograft in nude mice. J. Med. Chem. 46, 4586–46
Reddy, V. K., Sarkar, A., Valasinas, A., Marton, L. J., Basu, H. S., and Frydman, B. (2001) Cis-unsaturated analogues of 3,8,13,18,23-pentaazapentacosane (BE-4-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cell lines. J. Med. Chem. 44, 404–417.
Valasinas, A., Reddy, V. K., Blohkin, A. V., et al. (2003) Long-chain polyamines (oligoamines) exhibit strong cytotoxicities against human prostate cancer cells. Bioorg. Med. Chem. 11, 4121–4131.
Frydman, B., Bhattacharya, S., Sarkar, A., et al. (2004) Macrocyclic polyamines deplete cellular ATP levels and inhibit cell growth in human prostate cancer cells. J. Med. Chem. 47, 1051–105
Saab, N. H., West, E. E., Bieszk, N. C., et al. (1993) Synthesis and evaluation of unsymmetrically substituted polyamine analogues as inhibitors of spermidine/spermine-N1-acetyltransferase (SSAT) and as potential antitumor agents. J. Med. Chem. 36, 2998–3004.
McCloskey, D. E., Yang, J., Woster, P. M., Davidson, N. E., Casero, R. A., Jr. (1996) Polyamine analogue induction of programmed cell death in human lung tumor cells. Clin. Cancer Res. 2, 441–446.
Davidson, N. E., Hahm, H. A., McCloskey, D. E., Woster, P. M., and Casero, R. A. (1999) Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr. Related Cancer 6, 69–73.
Ha, H. C., Woster, P. M., Yager, J. D., and Casero, R. A., Jr. (1997) The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl. Acad. Sci. USA 94, 11,557–11,562.
Ha, H. C., Woster, P. M., and Casero, R. A., Jr. (1998) Unsymmetrically substituted polyamine analogue induces caspase-independent programmed cell death in Bcl-2 overexpressing cells. Cancer Res. 58, 2711–2714.
Webb, H. K., Wu, Z. Q., Sirisoma, N., Ha, H. C., Casero, R., A., Jr., and Woster, P. M. (1999) 1-[N-(Alkyl)amino]-11-[N-(ethyl)amino]-4,8-diazaundecanes: simple synthetic polyamine analogues which differentially alter tubulin polymerization. J. Med. Chem. 42, 1415–1421.
Ekstrom, J. L., Mathews, I. I., Stanley, B. A., Pegg, A. E., and Ealick, S. E. (1999) The crystal structure of human S-adenosylmethionine decarboxylase at 2.25 angstroms resolution reveals a novel fold. Structure (London) 7, 583.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Woster, P.M. (2006). Polyamine Structure and Synthetic Analogs. In: Wang, JY., Casero, R.A. (eds) Polyamine Cell Signaling. Humana Press. https://doi.org/10.1007/978-1-59745-145-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-59745-145-1_1
Publisher Name: Humana Press
Print ISBN: 978-1-58829-625-2
Online ISBN: 978-1-59745-145-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)